Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Compare major budgeting methods side by side, highlighting effectiveness, flexibility, and suitability for different financial contexts.
27,828 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Gap reports eight straight quarters of positive comps and a multi-decade margin high, prompting a televised reaction ...
Dogecoin has volatile history and meme-driven momentum. Here are three grounded reasons I won’t be buying in 2026, pl...
Snapdocs has named Jamie Mottern as vice president of lender growth, tasking her with expanding digital closings and ...
A CAPO oracle misconfiguration on Aave led to $27 million in liquidations and a torrent of bot activity. Aave promise...
A JPMorgan analysis shows a striking split in ETF flows since late February, with Bitcoin ETFs drawing money while go...
Eight years in stealth have shaped a new robotics venture from Travis Kalanick, with implications for workers, equity...
Amazon expands its delivery options by adding a paid three-hour window, changing Prime perks and costs for millions o...
The Treasury shows gross national debt reaching $39.016 trillion as of March 17, marking a historic milestone that wi...
Evernorth Holdings, a Ripple-backed company holding 473 million XRP, filed an S-4 to go public on Nasdaq through a $1...
A crisis-focused charity is pivoting to support TSA officers unpaid during a partial government shutdown. The effort ...
DoorDash sits near 52-week levels after a tough quarter that piled up costs from Deliveroo and grocery pushes. Yet Wa...